Back to Search
Start Over
Why VA-ECMO should not be used routinely in AMI-Cardiogenic Shock.
- Source :
-
Journal of Heart & Lung Transplantation . May2024, Vol. 43 Issue 5, p695-699. 5p. - Publication Year :
- 2024
-
Abstract
- This review summarizes the current evidence regarding efficacy and safety of venoarterial extracorporeal membrane oxygenation (VA-ECMO) in the setting of cardiogenic shock. Currently, there is evidence from 4 randomized controlled trials which all do not support a mortality benefit and increased complication rates by VA-ECMO. Based on current evidence, possible subgroups will be discussed and indications in selected very small patient groups be discussed. [ABSTRACT FROM AUTHOR]
Details
- Language :
- English
- ISSN :
- 10532498
- Volume :
- 43
- Issue :
- 5
- Database :
- Academic Search Index
- Journal :
- Journal of Heart & Lung Transplantation
- Publication Type :
- Academic Journal
- Accession number :
- 177031827
- Full Text :
- https://doi.org/10.1016/j.healun.2024.01.006